NuCana (NCNA) Other Non Operating Income (2017 - 2025)

NuCana (NCNA) reported Other Non Operating Income of $57197.1 for Q4 2025, down 89.8% on a YoY basis from $560890.3 in Q4 2024, and down 57.61% sequentially from $134936.2 in Q3 2025.

NuCana (NCNA) Other Non Operating Income (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Other Non Operating Income data on file, last reported at $57197.1 in Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 89.8% year-over-year to $57197.1; the trailing twelve-month figure through Dec 2025 stood at -$151654.4 (down 152.21% YoY), and the FY2025 full-year result was $255791.0, up 154.23% from the prior year.
  • Other Non Operating Income slipped to $57197.1 in Q4 2025, from $134936.2 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.9 million in Q2 2022 to a low of -$2.6 million in Q4 2022.
  • A 5-year average of -$56852.5 and a median of -$83857.4 in 2024 frame the typical range for Other Non Operating Income.
  • Peak annual rise in Other Non Operating Income reached 2643.39% in 2022, while the deepest fall reached 779.17% in 2022.
  • Tracing NCNA's Other Non Operating Income over 5 years: stood at -$297910.3 in 2021, then sank by 779.17% to -$2.6 million in 2022, then soared by 78.25% to -$569688.7 in 2023, then soared by 198.46% to $560890.3 in 2024, then slumped by 89.8% to $57197.1 in 2025.
  • Business Quant data shows NCNA's Other Non Operating Income at $57197.1 in Q4 2025, $134936.2 in Q3 2025, and -$269477.2 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 57,197.15
Sep 30, 2025 134,936.21
Jun 30, 2025 -269,477.23
Mar 31, 2025 -74,310.53
Dec 31, 2024 560,890.30
Sep 30, 2024 -297,539.74
Jun 30, 2024 -93,404.34
Mar 31, 2024 120,509.23
Dec 31, 2023 -569,688.72
Sep 30, 2023 711,876.85
Jun 30, 2023 -705,768.82
Mar 31, 2023 882,459.91
Dec 31, 2022 -2.62 Mn
Sep 30, 2022 61,284.51
Jun 30, 2022 3.87 Mn
Mar 31, 2022 -1.54 Mn
Dec 31, 2021 -297,910.34
Sep 30, 2021 13,785.83
Jun 30, 2021 -152,352.38
Mar 31, 2021 -933,529.36